when were glp 1 agonists approved for weight loss Comparative efficacy and safety of GLP-1 receptor reduction: A model-based meta-analysis of placebo-controlled trials GLP-1 Agonists Weight Loss Drugs

Analysis of pooled data To increase the sample size and BW range, five independent experiments totalling 145 rats were pooled into vehicle (V, n = 38), drug (CS + C + S, n = 57) and calorie restriction (WM + PF, n = 50) groups (Extended Data Table 1)

LMW-DS impaired fXa activity and prolonged PT, activated partial thromboplastin time, and thrombin time in human plasma (von Zur-Mhlen et al., 2019

4 Discussion In this cohort study, we found that 1) OLA monotherapy significantly decreased plasma levels of four L-carnitine metabolites in FES patients

Tan Q, Niu K, Zhu Y, Chen Z, Li Y, Li M, et al

Model curation provides researchers with the ability to obtain, adapt and implement such mathematical models, as outlined in this study, and is therefore a powerful tool in the arsenal of any systems biologist, pharmacologist or toxicologist